EP 3806831 A2 20210421 - LIPID NANOPARTICLES LOADED WITH CERANIB-2 AS ANTICANCER AGENTS
Title (en)
LIPID NANOPARTICLES LOADED WITH CERANIB-2 AS ANTICANCER AGENTS
Title (de)
MIT CERANIB-2 BELADENE LIPIDNANOPARTIKEL ALS MITTEL GEGEN KREBS
Title (fr)
NANOPARTICULES LIPIDIQUES CHARGÉES DE CERANIB -2, UTILISÉES EN TANT QU'AGENTS ANTICANCÉREUX
Publication
Application
Priority
- TR 201808578 A 20180618
- TR 2019050338 W 20190516
Abstract (en)
[origin: WO2020018049A2] The present invention relates to ceranib-2 formulations for use in treatment of cancer. More particularly, the present invention pertains to lipid nanoparticles comprising ceranib-2 as a medicament for treatment of cancer, such as breast cancer, lung cancer and colon cancer.
IPC 8 full level
A61K 9/51 (2006.01); A61K 31/4704 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 9/5123 (2013.01); A61K 31/4704 (2013.01); A61P 35/00 (2017.12)
Citation (search report)
See references of WO 2020018049A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020018049 A2 20200123; WO 2020018049 A3 20200227; EP 3806831 A2 20210421
DOCDB simple family (application)
TR 2019050338 W 20190516; EP 19812871 A 20190516